Onderneming BBI Life Sciences Corporation
Aandelen
1035
KYG1089Y1180
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Luo Jia Wang
CEO | Chief Executive Officer | 55 | - |
Xiao Lei Gu
DFI | Director of Finance/CFO | 43 | 11-09-15 |
Jin Wang
PSD | President | 53 | - |
Bin Liu
BRD | Director/Board Member | 41 | 30-10-19 |
Mi Zhou
BRD | Director/Board Member | 41 | - |
Heng Hu
SEC | Corporate Secretary | 44 | - |
Sau Mei Ng
SEC | Corporate Secretary | 47 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Qi Song Wang
CHM | Chairman | 83 | - |
Jian Jun Liu
BRD | Director/Board Member | 56 | 16-01-14 |
Luo Jia Wang
CEO | Chief Executive Officer | 55 | - |
Jin Wang
PSD | President | 53 | - |
Mi Zhou
BRD | Director/Board Member | 41 | - |
Bin Liu
BRD | Director/Board Member | 41 | 30-10-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 560 522 623 | 249 121 411 ( 44,44 %) | 0 | 44,44 % |
Bedrijfsgegevens
BBI Life Sciences Corp.
No. 698, Xiangmin Road Songjiang District
201611, Shanghai
+
http://www.bbi-lifesciences.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,28% | 42,68 mld. | |
-3,99% | 42,4 mld. | |
+45,32% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,36% | 24,94 mld. | |
-21,47% | 18,96 mld. | |
+27,58% | 12,3 mld. | |
-2,75% | 11,95 mld. | |
-2,02% | 11,55 mld. |